CSS
ATOS icon

Cubist Systematic Strategies’s Atossa Therapeutics ATOS Stock Holding History

Cubist Systematic Strategies’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-741
Closed -$9.22K – 3004
2025
Q2 		$9.22K Buy
+741
New +$8.86K ﹤0.01% 2841
2022
Q3 		– Sell
-1,347
Closed -$22K – 4412
2022
Q2 		$22K Buy
+1,347
New +$21.2K ﹤0.01% 4203
2021
Q4 		– Sell
-1,191
Closed -$58K – 3453
2021
Q3 		$58K Buy
1,191
+841
+240% +$48.9K ﹤0.01% 2822
2021
Q2 		$33K Buy
+350
New +$18.5K ﹤0.01% 2821

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Cubist Systematic Strategies's ATOS Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of Atossa Therapeutics (ATOS) in Q3 2025, closing a stake of 741 shares — an estimated $9.22K sold.

Cubist Systematic Strategies first reported a position in ATOS in Q2 2021 and held it in 4 quarters. The position peaked at $58K in Q3 2021. 66 funds tracked by Wall St. Rank hold ATOS as of Q3 2025.

  • Cubist Systematic Strategies reported no remaining Atossa Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 741 Atossa Therapeutics shares in Q3 2025, an estimated $9.22K.
  • Cubist Systematic Strategies first reported a position in Atossa Therapeutics in Q2 2021 and held it in 4 quarters.
  • Cubist Systematic Strategies's Atossa Therapeutics position peaked at $58K in Q3 2021.
  • 66 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.